RODMAN&RENSHAW Stock Recommendations and Price Targets

This is a list of recent ratings by RODMAN&RENSHAW.

Date	Company Name	Action	Current Price	Rating	Impact on Share Price
12/6/2024	THAR Tharimmune	Upgrade	$2.00	Strong-Buy	N/A
11/14/2024	ADIL Adial Pharmaceuticals	Upgrade	$1.00	Strong-Buy	N/A
11/14/2024	RMTI Rockwell Medical	Upgrade	$2.00	Strong-Buy	N/A
11/14/2024	EPRX Eupraxia Pharmaceuticals	Upgrade	$3.00	Strong-Buy	N/A
11/14/2024	ACHV Achieve Life Sciences	Upgrade	$4.00	Strong-Buy	N/A
11/14/2024	OMER Omeros	Upgrade	$8.00	Strong-Buy	N/A
11/5/2024	BCAX Bicara Therapeutics	Upgrade	$18.00	Strong-Buy	Low
10/29/2024	QNCX Quince Therapeutics	Upgrade	$2.00	Strong-Buy	High
10/23/2024	ANRO Alto Neuroscience	Downgrade	$4.00	Strong-Buy ➝ Hold	Medium
10/9/2024	NKTX Nkarta	Upgrade	$2.00	Strong-Buy	High
10/9/2024	KYTX Kyverna Therapeutics	Upgrade	$4.00	Strong-Buy	High
9/30/2024	MIRA MIRA Pharmaceuticals	Upgrade	$1.00	Strong-Buy	Low
9/26/2024	BMEA Biomea Fusion	Upgrade	$5.00	Strong-Buy	Low